EUVIMEDEUVIMED entdecken
Crossref

The Mitochondrial Fusion Promoter M1 Mitigates Cigarette Smoke-Induced Airway Inflammation and Oxidative Stress via the PI3K-AKT Signaling Pathway

Tingting Zeng, Lian Liu, Dan Xu, Tao Wang, Yanqiu Wu, Jiangyue Qin, Lijuan Gao, Mei Chen, Xiaohua Li, Diandian Li, Jun Chen, Yongchun Shen und 1 weitere

Lung · 2025-12 · 203 (1)

DOI: 10.1007/s00408-024-00766-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung, online erschienen am 03.12.2024. Verfasst von Tingting Zeng und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy of China, Division of Pulmonary Diseases, Department of Pulmonary and Critical Care Medicine, West China Hospital …. Hauptthemen laut MEDLINE: Oxidative Stress, Signal Transduction, Proto-Oncogene Proteins c-akt, Mitochondrial Dynamics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Sichuan Key Research and Development Program, the China Posdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressSignal TransductionProto-Oncogene Proteins c-aktMitochondrial DynamicsPhosphatidylinositol 3-KinasesAnimalsMiceHumansSmokeCigarette SmokingCytokinesMaleLungMitochondriaMice, Inbred C57BLReactive Oxygen SpeciesCell LineDisease Models, AnimalPneumoniaEpithelial Cells

Stichwörter der Autor:innen

Airway inflammationChronic obstructive pulmonary diseaseMitochondrial fusion promoter M1Oxidative stress

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSmokeCytokinesReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy of China, Division of Pulmonary Diseases, Department of Pulmonary and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
  • Department of Respiratory and Critical Care Medicine, Sixth People's Hospital of Chengdu, Chengdu, 610051, China.
  • State Key Laboratory of Biotherapy of China, Division of Pulmonary Diseases, Department of Pulmonary and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China. junchen@scu.edu.cn.
  • State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, China. junchen@scu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • the Sichuan Key Research and Development Program
  • the China Posdoctoral Science Foundation
  • the 1⋅3⋅5 project for disciplines of excellence, West China Hospital, Sichuan University

Zitieren

APA

Zeng, T., Liu, L., Xu, D., Wang, T., Wu, Y., Qin, J., Gao, L., Chen, M., Li, X., Li, D., Chen, J., Shen, Y., & Wen, F. (2025). The Mitochondrial Fusion Promoter M1 Mitigates Cigarette Smoke-Induced Airway Inflammation and Oxidative Stress via the PI3K-AKT Signaling Pathway. Lung, 203(1). https://doi.org/10.1007/s00408-024-00766-3

Vancouver

Zeng T, Liu L, Xu D, Wang T, Wu Y, Qin J, et al. The Mitochondrial Fusion Promoter M1 Mitigates Cigarette Smoke-Induced Airway Inflammation and Oxidative Stress via the PI3K-AKT Signaling Pathway. Lung. 2025;203(1). doi:10.1007/s00408-024-00766-3

BibTeX
@article{Zeng2025,
  author = {Zeng, Tingting and Liu, Lian and Xu, Dan and Wang, Tao and Wu, Yanqiu and Qin, Jiangyue and Gao, Lijuan and Chen, Mei and Li, Xiaohua and Li, Diandian and Chen, Jun and Shen, Yongchun and Wen, Fuqiang},
  title = {The Mitochondrial Fusion Promoter M1 Mitigates Cigarette Smoke-Induced Airway Inflammation and Oxidative Stress via the PI3K-AKT Signaling Pathway},
  journal = {Lung},
  year = {2025},
  volume = {203},
  number = {1},
  doi = {10.1007/s00408-024-00766-3}
}
Kostenlos starten →